246 related articles for article (PubMed ID: 14673185)
1. Cholecystokinin activates CCKB receptors to excite cells and depress EPSCs in the rat rostral nucleus accumbens in vitro.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
J Physiol; 2004 Feb; 555(Pt 1):71-84. PubMed ID: 14673185
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin inhibits evoked inhibitory postsynaptic currents in the rat nucleus accumbens indirectly through gamma-aminobutyric acid and gamma-aminobutyric acid type B receptors.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
J Neurosci Res; 2005 Feb; 79(3):412-20. PubMed ID: 15605383
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin-2 receptors couple to cAMP-protein kinase A to depress excitatory synaptic currents in rat nucleus accumbens in vitro.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
Can J Physiol Pharmacol; 2006 Feb; 84(2):203-11. PubMed ID: 16900946
[TBL] [Abstract][Full Text] [Related]
4. Enaminones and norepinephrine employ convergent mechanisms to depress excitatory synaptic transmission in the rat nucleus accumbens in vitro.
Kombian SB; Ananthalakshmi KV; Edafiogho IO
Eur J Neurosci; 2006 Nov; 24(10):2781-8. PubMed ID: 17156204
[TBL] [Abstract][Full Text] [Related]
5. Substance P depresses excitatory synaptic transmission in the nucleus accumbens through dopaminergic and purinergic mechanisms.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
J Neurophysiol; 2003 Feb; 89(2):728-37. PubMed ID: 12574450
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
Lanza M; Makovec F
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):33-8. PubMed ID: 10651144
[TBL] [Abstract][Full Text] [Related]
7. Cellular action of cholecystokinin-8S-mediated excitatory effects in the rat periaqueductal gray.
Yang YM; Chung JM; Rhim H
Life Sci; 2006 Sep; 79(18):1702-11. PubMed ID: 16797032
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin octapeptide increases spontaneous glutamatergic synaptic transmission to neurons of the nucleus tractus solitarius centralis.
Baptista V; Zheng ZL; Coleman FH; Rogers RC; Travagli RA
J Neurophysiol; 2005 Oct; 94(4):2763-71. PubMed ID: 16093341
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin B-type receptors mediate a G-protein-dependent depolarizing action of sulphated cholecystokinin ocatapeptide (CCK-8s) on rodent neonatal spinal ventral horn neurons.
Oz M; Yang KH; Shippenberg TS; Renaud LP; O'Donovan MJ
J Neurophysiol; 2007 Sep; 98(3):1108-14. PubMed ID: 17581850
[TBL] [Abstract][Full Text] [Related]
10. Substance P and cocaine employ convergent mechanisms to depress excitatory synaptic transmission in the rat nucleus accumbens in vitro.
Kombian SB; Ananthalakshmi KV; Zidichouski JA; Saleh TM
Eur J Neurosci; 2009 Apr; 29(8):1579-87. PubMed ID: 19385993
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
Wan S; Coleman FH; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro.
Voigt M; Wang RY; Westfall TC
J Pharmacol Exp Ther; 1986 Apr; 237(1):147-53. PubMed ID: 3958963
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.
Mitchell VA; Jeong HJ; Drew GM; Vaughan CW
Neuropsychopharmacology; 2011 Aug; 36(9):1801-10. PubMed ID: 21525858
[TBL] [Abstract][Full Text] [Related]
14. Dopamine modulates synaptic transmission in the nucleus of the solitary tract.
Kline DD; Takacs KN; Ficker E; Kunze DL
J Neurophysiol; 2002 Nov; 88(5):2736-44. PubMed ID: 12424308
[TBL] [Abstract][Full Text] [Related]
15. Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro.
Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
Eur J Neurosci; 2003 Jul; 18(2):303-11. PubMed ID: 12887412
[TBL] [Abstract][Full Text] [Related]
16. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.
Gerhardt GA; Friedemann M; Brodie MS; Vickroy TW; Gratton AP; Hoffer BJ; Rose GM
Brain Res; 1989 Oct; 499(1):157-63. PubMed ID: 2804664
[TBL] [Abstract][Full Text] [Related]
17. The excitatory effect of cholecystokinin on rat neostriatal neurons: ionic and molecular mechanisms.
Wu T; Wang HL
Eur J Pharmacol; 1996 Jun; 307(2):125-32. PubMed ID: 8832213
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
Reum T; Schäfer U; Marsden CA; Fink H; Morgenstern R
Neuropeptides; 1997 Feb; 31(1):82-8. PubMed ID: 9574843
[TBL] [Abstract][Full Text] [Related]
19. Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release.
Pérez de la Mora M; Hernández-Gómez AM; Arizmendi-García Y; Jacobsen KX; Lara-García D; Flores-Gracia C; Crespo-Ramírez M; Gallegos-Cari A; Nuche-Bricaire A; Fuxe K
Eur J Neurosci; 2007 Dec; 26(12):3614-30. PubMed ID: 18088282
[TBL] [Abstract][Full Text] [Related]
20. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
Gronier B; Debonnel G
Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
